Page 115 - Traité de chimie thérapeutique 6 Médicaments antitumoraux
P. 115

4 MOUTARDES à L'AZOTE                                     71

             BIBLIOGRAPHIE
             BERGEL F., STOCK J.A., Melphalan, U.S. Patent 3,032,584, 1962.
             LEDNICER D., MITSHER L.A., The Organic Chemistry of Drug Synthesis, John Wiley and
               Sons, Inc., vol. 2, (1980), 120-121 et 299; ibid. vol. 3 (1984), 82-93.
             FEYNS L.V., Melphalan, in Analytical Profiles ofDrug Substances, Florey K. ed, Academic
               Press, Inc., 1984, vol. 13, 265-304.
             TARIQ M., AL-SADR A., Chlorambucil, in Analytical Profiles of Drug Substances,
               Florey K. ed., Academic Press, Inc., 1987, vol. 16, 85-118.
             MARTY M. et al., Anticancéreux, in Pharmacologie Clinique; Bases de la Thérapeutique,
               Giraud J.P., Expansion Scientifique Française, Paris, 1988, 1894-1958.
             CALABRESI P., CHABNER B.A., Antineoplasic agents, in The Pharmacological Basis of
               Therapeutics, Goodman Gilman A. ed., Pergamon Press, Inc., 1990, 8th ed., 1209-
               1263.
             PRATT W.B. et al., Sorne Milestones in the Development of Cancer Chemotherapy
               (Ch. 2). in The Anticancer Drugs (2nd ed), Oxford University Press, 1994, 17-25;
               108-122.
             CRAUSE-MANCIET S. et al., Monographies, in Médicaments Anticancéreux, Husson
               M.C., Becker A. (coord.), APHIF, Éditions Médicales Internationales, Cachan, 1995,
               21-192.
             TRANCHAND B., Guide Pratique de Pharmacocinétique Clinique en Oncologie, (2° éd.),
               Editions Frison-Roche, Paris, 1997.
             LEDNICER D., Strategies for Organic Drug Synthesis and Design, John Wiley and Sons,
               Inc., 1998, 91-92.
   110   111   112   113   114   115   116   117   118   119   120